Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Colorectal Neoplasms

  Free Subscription


14.09.2020

1 Am J Clin Oncol
1 Am J Epidemiol
2 BMC Cancer
1 Br J Surg
3 Cancer Lett
1 Clin Cancer Res
1 Eur J Cancer
1 Eur J Surg Oncol
1 Gastroenterology
1 Gut
2 Int J Colorectal Dis
2 Int J Oncol
1 J Clin Oncol
2 Oncol Rep
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Oncol

  1. BOEHMER U, Clark MA, Ozonoff A, Winter M, et al
    Survivors' Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation.
    Am J Clin Oncol. 2020;43:660-666.
    PubMed         Abstract available


    Am J Epidemiol

  2. HINES RB, Jiban MJH, Lee E, Odahowski CL, et al
    Characteristics Associated with Nonreceipt of Surveillance Testing and the Relationship with Survival in Stage II and III Colon Cancer.
    Am J Epidemiol. 2020 Sep 9. pii: 5902908. doi: 10.1093.
    PubMed         Abstract available


    BMC Cancer

  3. KOHOUTOVA D, Forstlova M, Moravkova P, Cyrany J, et al
    Bacteriocin production by mucosal bacteria in current and previous colorectal neoplasia.
    BMC Cancer. 2020;20:39.
    PubMed         Abstract available

  4. COEBERGH VAN DEN BRAAK RRJ, Ten Hoorn S, Sieuwerts AM, Tuynman JB, et al
    Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.
    BMC Cancer. 2020;20:850.
    PubMed         Abstract available


    Br J Surg

  5. MA J, Whittaker Y, Chandran P
    Male Sexual Dysfunction after Pelvic Surgery for Colorectal Cancer.
    Br J Surg. 2020 Sep 8. doi: 10.1002/bjs.12033.
    PubMed        


    Cancer Lett

  6. WU Q, Liu W, Wang J, Zhu L, et al
    Exosomal noncoding RNAs in colorectal cancer.
    Cancer Lett. 2020 Sep 5. pii: S0304-3835(20)30451.
    PubMed         Abstract available

  7. ROTHKAMM K, Christiansen S, Rieckmann T, Horn M, et al
    Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays.
    Cancer Lett. 2020;493:179-188.
    PubMed         Abstract available

  8. ZHAO H, Yan C, Hu Y, Mu L, et al
    Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids.
    Cancer Lett. 2020 Sep 5. pii: S0304-3835(20)30458.
    PubMed         Abstract available


    Clin Cancer Res

  9. DE GOOYER JM, Elekonawo FMK, Bos DL, van der Post RS, et al
    Multimodal CEA-targeted image-guided colorectal cancer surgery using 111In-labeled SGM-101.
    Clin Cancer Res. 2020 Sep 8. pii: 1078-0432.CCR-20-2255.
    PubMed         Abstract available


    Eur J Cancer

  10. SOBRERO AF, Puccini A, Shi Q, Grothey A, et al
    A new prognostic and predictive tool for shared decision making in stage III colon cancer.
    Eur J Cancer. 2020;138:182-188.
    PubMed         Abstract available


    Eur J Surg Oncol

  11. SORRENTINO L, Serra F, Cabry F, Cauteroq N, et al
    Peritoneal carcinomatosis from colorectal cancer in the pediatric population: Cytoreductive surgery and HIPEC. A systematic review.
    Eur J Surg Oncol. 2020 Aug 27. pii: S0748-7983(20)30713.
    PubMed         Abstract available


    Gastroenterology

  12. GUPTA S
    Cumulative risk for incident and fatal colorectal cancer after polypectomy.
    Gastroenterology. 2020 Sep 3. pii: S0016-5085(20)35128.
    PubMed        


    Gut

  13. BIBAULT JE, Chang DT, Xing L
    Development and validation of a model to predict survival in colorectal cancer using a gradient-boosted machine.
    Gut. 2020 Sep 4. pii: gutjnl-2020-321799. doi: 10.1136/gutjnl-2020-321799.
    PubMed         Abstract available


    Int J Colorectal Dis

  14. CRACCO N, Todaro V, Pedrazzi G, Del Rio P, et al
    The risk of lymph node metastasis in T1 colorectal cancer: new parameters to assess the degree of submucosal invasion.
    Int J Colorectal Dis. 2020 Sep 8. pii: 10.1007/s00384-020-03738.
    PubMed         Abstract available

  15. WANG S, Yuan B, Wang Y, Li M, et al
    Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis.
    Int J Colorectal Dis. 2020 Sep 10. pii: 10.1007/s00384-020-03734.
    PubMed         Abstract available


    Int J Oncol

  16. KOYAMA M, Kitazawa M, Nakamura S, Matsumura T, et al
    Lowdose trametinib and BclxL antagonist have a specific antitumor effect in KRASmutated colorectal cancer cells.
    Int J Oncol. 2020 Sep 2. doi: 10.3892/ijo.2020.5117.
    PubMed         Abstract available

  17. FENG J, Xiao T, Lu SS, Hung XP, et al
    ANXA1derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
    Int J Oncol. 2020 Sep 7. doi: 10.3892/ijo.2020.5119.
    PubMed         Abstract available


    J Clin Oncol

  18. MLECNIK B, Bifulco C, Bindea G, Marliot F, et al
    Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.
    J Clin Oncol. 2020 Sep 8:JCO1903205. doi: 10.1200/JCO.19.03205.
    PubMed         Abstract available


    Oncol Rep

  19. WANG X, Tao G, Huang D, Liang S, et al
    Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA4855p/CKS1B axis.
    Oncol Rep. 2020 Sep 7. doi: 10.3892/or.2020.7758.
    PubMed         Abstract available

  20. YANG H, Li Q, Wu Y, Dong J, et al
    Long noncoding RNA RP11400N13.3 promotes the progression of colorectal cancer by regulating the miR47223p/P2RY8 axis.
    Oncol Rep. 2020 Sep 7. doi: 10.3892/or.2020.7755.
    PubMed         Abstract available


    PLoS One

  21. PASTORINO R, Basile M, Tognetto A, Di Marco M, et al
    Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy.
    PLoS One. 2020;15:e0235038.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. TAN J, Liu R, Zhu G, Umbricht CB, et al
    TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel.
    Proc Natl Acad Sci U S A. 2020;117:15846-15851.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: